Apogee Therapeutics, Inc. (APGE)
68.68
-2.41
(-3.39%)
USD |
NASDAQ |
Mar 17, 13:27
Apogee Therapeutics Shareholders Equity (Quarterly) : 903.88M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Rhythm Pharmaceuticals, Inc. | 139.07M |
| Praxis Precision Medicines, Inc. | 878.14M |
| Celcuity, Inc. | 116.96M |
| Rapt Therapeutics, Inc. (DELISTED) | 151.98M |
| Disc Medicine, Inc. | 739.83M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 937.13M |
| Total Liabilities (Quarterly) | 33.25M |
| Debt to Equity Ratio | 0.0098 |
| Current Ratio | 26.57 |
| Net Debt Paydown Yield | 0.01% |